Orencia 125 MG/ML syringeml
Ended Awarded Last action
- Contract number
- SPE2DR26F4D0G
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $8,364
Award facts
- Contract value 100% obligated
- $8,363.88 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $8,363.88 delivery order to AmerisourceBergen Drug Corp for Orencia 125 mg/mL syringes. This is a firm fixed price, non-set-aside contract awarded on December 8, 2025, with an ultimate completion date of December 9, 2025. The product will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Orencia (abatacept) is a biologic immunosuppressant medication used to treat rheumatoid arthritis and other autoimmune conditions, making this delivery order part of the DLA's broader pharmaceutical supply chain supporting military and federal healthcare systems.
This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of medications and medical supplies to support military healthcare programs worldwide. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, has demonstrated its capability to meet federal procurement requirements through multiple competitively awarded contracts with the DLA covering specialty medications, brand-name and generic drugs, vaccines, and specialized medical supplies across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26F4D0G?
SPE2DR26F4D0G was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 8, 2025.
How much is contract SPE2DR26F4D0G worth?
The government has obligated $8,364 on SPE2DR26F4D0G.
Is contract SPE2DR26F4D0G an order under another contract?
Yes. SPE2DR26F4D0G is a delivery order under SPE2DR25D3012, an indefinite delivery contract.
Was contract SPE2DR26F4D0G competed?
The extent of competition for SPE2DR26F4D0G was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award